Safarulla et al. showed that brain-metastatic breast cancer cells (MDA-MB231BrM2a) modulate neutrophil function, most likely by the secretion of CXCR2 ligands (particularly CXCL1) [144]. Here, CXCR2 is linked to breast carcinoma.